Human astrocytes from patients with late-onset Alzheimer's disease have lower tryptophan levels and higher kynurenine levels, demonstrating that the IDO1-kynurenine pathway is active in the human Alzheimer's brain.

factualpending

Speaker

Unidentified Speaker — Metabolizing Alzheimer’s: A New Key to Stopping Brain Damage [XkTIvIhP7jQ]

Evidence Quote

“human astrocytes from patients with the most common form of Alzheimer's disease late onset Alzheimer's disease also had lower tryptophan and higher kyn levels”

Source

Metabolizing Alzheimer’s: A New Key to Stopping Brain Damage— Nick Norwitz MD PhD
Created: 8/10/2026, 10:47:48 PM

Your notes

Loading notes...